Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What is the Projected CAGR for the Vertebroplasty Needles Market Size from 2025 to 2034?

The market size for vertebroplasty needles has witnessed swift growth in the past few years. It is forecasted to rise from $1 billion in 2024 to $1.12 billion in 2025, exhibiting a compound annual growth rate (CAGR) of 12.2%. The growth during the historical period is thanks to factors like a growing older population, enhancements in minimally invasive procedures, increased awareness, rising healthcare spending, development of healthcare infrastructure, and governmental aid and financing.

The market for vertebroplasty needles is projected to expand significantly in the coming years, reaching a value of $1.77 billion by 2029, with a Compound Annual Growth Rate (CAGR) of 12.2%. The growth within the forecast period can be attributed to factors such as the rising cases of osteoporosis, the increasing preference for minimally invasive surgical methods, growth in developing markets, an aging worldwide population, increasing expenditure on healthcare, and ongoing professional training. Key trends within the forecast period comprise the integration of technology, innovative needle design, AI and machine learning, personalized health care, telemedicine application, automation and robotics, as well as the implementation of sustainability initiatives.

Download a free sample to assess the report’s scope and structure:

https://www.thebusinessresearchcompany.com/sample.aspx?id=17292&type=smp

What are the Fundamental Drivers and Innovations Shaping the Vertebroplasty Needles Market?

The vertebroplasty needles market is anticipated to expand in response to an expected rise in the number of spinal injuries. Spinal injuries, which involve harm to the spinal cord, vertebrae, or surrounding tissues, can lead to pain, mobility impairment, or paralysis. Numerous factors, such as aging populations, increased participation in sports, and high rates of car accidents, are driving the surge in spinal injuries. Vertebroplasty needles play a pivotal role in the treatment of spinal injuries by facilitating the precise injection of bone cement into fractured vertebrae to relieve pain and restore backbone strength. For instance, the Spinal Injuries Association, a US-based entity specializing in spinal cord injury care, reported about 4,400 new spinal cord injury cases in the UK in May 2024, which is equivalent to one individual becoming paralyzed every two hours. This culminated in an estimated total of 105,000 spinal cord injuries in 2024. Thus, the upswing in spinal injuries is fueling the growth of the vertebroplasty needles market.

How Is the Vertebroplasty Needles Market Segmented?

The vertebroplasty needlesmarket covered in this report is segmented –

1) By Type: 2.5×100, 2.5×130, 3.2×100, 3.2×130

2) By Product Type: Bone Cement Needles, Aspiration Needles

3) By Procedure Type: Percutaneous Vertebroplasty, Kyphoplasty

Subsegments

1) By 2.5×100: Single Use 2.5×100 Needle, Reusable 2.5×100 Needle

2) By 2.5×130: Single Use 2.5×130 Needle, Reusable 2.5×130 Needle

3) By 3.2×100: Single Use 3.2×100 Needle, Reusable 3.2×100 Needle

4) By 3.2×130: Single Use 3.2×130 Needle, Reusable 3.2×130 Needle

Request customized data on this market:

https://www.thebusinessresearchcompany.com/customise?id=17292&type=smp

Which Regions Are Driving the Next Phase of the Vertebroplasty Needles Market Growth?

North America was the largest region in the vertebroplasty needles market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the vertebroplasty needles market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

What Key Trends Are Shaping the Future of the Vertebroplasty Needles Market?

Leading enterprises in the vertebroplasty needles sector are concentrating on the generation of groundbreaking technologies like regenerative biomaterials. This aim is to boost the efficacy of spinal treatments, augment patient results, and minimize recuperation durations. Regenerative biomaterials are specifically designed to facilitate the repair and rejuvenation of impaired tissues by imitating the intrinsic extracellular matrix. For example, RevBio, which is a clinical-stage medical device company located in the US, initiated a trial in November 2022 to evaluate the effectiveness of Tetranite, its regenerative biomaterial. Tetranite is an injectable bone adhesive with noteworthy effects on vertebroplasty and associated procedures. This material can join bone fragments and fill gaps, providing immediate steadiness during the healing phase. This feature is vital in vertebroplasty where the fortification of fractured vertebrae plays a key role in recuperation.

View the full report here:

https://www.thebusinessresearchcompany.com/report/vertebroplasty-needles-global-market-report

How Is the Vertebroplasty Needles Market Defined and What Are Its Core Parameters?

A vertebroplasty needle is a specialized medical instrument used in the minimally invasive surgical procedure known as vertebroplasty. This procedure is typically performed to treat compression fractures in the spine, often caused by osteoporosis or trauma. The needle is used to inject bone cement (usually a type of acrylic resin) directly into the fractured vertebra under imaging guidance, such as fluoroscopy or a computed tomography scan (CT scan), to stabilize the bone and relieve pain. The needle is designed to be precise and minimally traumatic to surrounding tissues during the cement injection process.

Purchase the full report and get a swift delivery:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=17292

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model